IND Swift Laboratories Ltd INDSWFTLAB-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 02/26/21 IST
76.20quote price arrow down-2.20 (-2.81%)
Volume
78,330
52 week range
15.00 - 87.45

...

Loading . . .

KEY STATS

  • Open76.40
  • Day High77.60
  • Day Low75.05
  • Prev Close78.40
  • 52 Week High87.45
  • 52 Week High Date01/11/21
  • 52 Week Low15.00
  • 52 Week Low Date03/06/20
  • Market Cap61.01M
  • Shares Out59.09M
  • 10 Day Average Volume153,507.25
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change282.91

RATIOS/PROFITABILITY

  • EPS (TTM)7.31
  • P/E (TTM)10.43
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/22/2006
  • Div Amount1.50
  • Split Date-
  • Split Factor-

Latest IND Swift Laboratories Ltd News

There is no recent news for this security.

Latest INDSWFTLAB-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Ind-Swift Laboratories Limited is an India-based company, which is engaged in manufacturing of active pharmaceutical ingredients (APIs). The Company operates through the bulk drugs and pharmaceuticals segment. The Company has a product portfolio of approximately 50 products across approximately 15 therapeutic segments. It manufactures Clarithromycin powder/granules, Atorvastatin Calcium Crystalline, Roxithromycin and Nitazoxanide. It also manufactures Nateglinide...
Sanjeev Mehta
Non-Executive Chairman
N. Munjal
Chief Executive Officer
Sahil Munjal
President
Lalit Wadhwa
Chief Operating Officer
N. Bansal
Chief Financial Officer
Uresh Raval
Vice President
Address
SCO 850
Shivalik Enclave, NAC, Manimajra
Chandigarh
160101
India